KeyBanc Capital Markets adjusted its price target on Inspire Medical Systems (NYSE:INSP) shares, lowering it to $234 from $236, while maintaining an Overweight rating on the stock. The revision ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

TUPELO — For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough solution. Larry Ferguson, 77, of Pontotoc, is among those whose ...

In the search for effective treatments for sleep apnea ... to implant a chip. A device is then attached to the chin, easily controlled remotely, via a remote control or a smartphone. The Inspire ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment ... which offers a less intrusive alternative to CPAP and Inspire Therapy. Despite a high burn rate, Nyxoah ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...